Scrip is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Nanjing MeiRui Pharma Co. Ltd

Division of GlaxoSmithKline PLC
www.meirui.com

Latest From Nanjing MeiRui Pharma Co. Ltd

Deal Watch: Bristol Shores Up Cancer, NASH Pipelines With International Deals

Partnership with France’s Enterome will add a microbiome aspect to Bristol’s immuno-oncology efforts, while its license of Japanese firm Nitto Denko’s siRNA technology could bolster NASH combo therapy development. Meanwhile, Eagle moves into biosimilars with the purchase of Arsia for up to $78m.

Business Strategies Commercial
See All

Company Information

  • Industry
  • In Vitro Diagnostics
    • Chemistry, Immunoassay
  • Medical Devices
    • Monitoring Equipment & Devices
  • Pharmaceuticals
  • Therapeutic Areas
  • Gynecological, Urological
  • Immune Disorders
  • Respiratory, Pulmonary
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Asia
      • China
  • Parent & Subsidiaries
  • GlaxoSmithKline PLC
  • Senior Management
  • Contact Info
  • Nanjing MeiRui Pharma Co. Ltd
    Phone: (86) 021 62880666
    1266 Nanjing Rd. W, Plaza 66
    40th Fl.
    Shanghai, 200040
    China
Advertisement
Advertisement
UsernamePublicRestriction

Register